1. Signaling Pathways
  2. Immunology/Inflammation
  3. Toll-like Receptor (TLR)
  4. Toll-like Receptor (TLR) Inhibitors

Toll-like Receptor (TLR) Inhibitors

TLR3

TLR8

TLR9

TLR2

TLR4

TLR7

TLR1

TLR6

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

Toll-like Receptor (TLR) Inducers, Inhibitors, Agonists, Antagonists, Activators & Modulators
Product Name TLR3 TLR8 TLR9 TLR2 TLR4 TLR7 TLR1 TLR6 Purity
Lipopolysaccharides, from E. coli O55:B5        
TLR4
     
Resiquimod  
TLR8
     
TLR7
    99.95%
Resatorvid        
TLR4
      99.95%
Imiquimod          
TLR7
    99.96%
C29      
TLR2
        ≥98.0%
Hydroxychloroquine sulfate    
TLR9
   
TLR7
    99.99%
Pam3CSK4 TFA      
TLR2
   
TLR1
  99.66%
CU-CPT 4a
TLR3, IC50: 3.44 μM (in RAW 264.7 cells)
              99.34%
Enpatoran  
TLR8, IC50: 24.1 nM (in HEK293 cells)
TLR8, IC50: 620 nM (in peripheral blood mononuclear cells (PBMCs))
TLR8, IC50: 120 nM ( in whole blood (WB) cells)
     
TLR7, IC50: 11.1 nM (in HEK293 cells)
TLR7, IC50: 68.3 nM (in peripheral blood mononuclear cells (PBMCs))
TLR7, IC50: 2.2 nM ( in whole blood (WB) cells)
    99.77%
ODN 1826    
TLR9
         
Agatolimod sodium    
TLR9
         
Diprovocim      
TLR2
   
TLR1
  98.35%
Imiquimod hydrochloride          
TLR7
    99.77%
ODN 1826 sodium    
TLR9
          99.51%
Agatolimod    
TLR9
         
TLR4-IN-C34        
TLR4
      99.90%
CU-CPT22      
TLR2
   
TLR1
  ≥99.0%
Telratolimod  
TLR8
     
TLR7
    98.98%
Polyinosinic-polycytidylic acid sodium
TLR3
              99.40%
Motolimod  
TLR8
            98.12%
Atractylenolide I    
TLR9
   
TLR7
    99.94%
Physcion        
TLR4
      99.10%
ODN 2216    
TLR9
         
AT791    
TLR9, IC50: 0.04 μM
   
TLR7, IC50: 3.33 μM
    98.77%
Schaftoside        
TLR4
      99.67%
ODN 1018    
TLR9
         
CU-T12-9      
TLR2, EC50: 52.9 nM (in HEK-Blue cells)
   
TLR1, EC50: 52.9 nM (in HEK-Blue cells)
  98.94%
MMG-11      
TLR2
        99.11%
Selgantolimod  
TLR8
            98.23%
ODN 2395    
TLR9
          98.39%
Enpatoran hydrochloride  
TLR8, IC50: 24.1 nM
     
TLR7, IC50: 11.1 nM
    99.33%
Neoseptin 3        
TLR4, EC50: 18.5 μM
      99.57%
CL097  
TLR8
     
TLR7
    99.89%
CL075  
TLR8
            99.25%
Sparstolonin B      
TLR2
TLR4
      99.54%
FSL-1 TFA      
TLR2
     
TLR6
99.65%
ODN 1668    
TLR9
         
D-Glucuronic acid        
TLR4
     
Okanin        
TLR4
      99.98%
ODN 2395 sodium    
TLR9
         
TLR9-IN-1    
human TLR9, IC50: 7 nM
          99.80%
TLR7/8 agonist 1 dihydrochloride  
TLR8
     
TLR7
    99.70%
TLR7/8-IN-1  
TLR8
     
TLR7
    99.92%
Robinin      
TLR2
TLR4
      98.77%
Gardiquimod  
TLR8
     
TLR7
    99.91%
Isofraxidin        
TLR4
      99.00%
ODN 1668 sodium    
TLR9
          ≥99.0%
Gardiquimod diTFA  
TLR8
     
TLR7
    ≥99.0%
Loxoribine          
TLR7
    99.64%
MD2-IN-1        
TLR4
      99.89%
IAXO-102        
TLR4
      ≥98.0%
TLR7/8 agonist 1  
TLR8
     
TLR7
   
E6446 dihydrochloride    
TLR9
   
TLR7
    99.96%
NecroX-7        
TLR4
      99.69%
L48H37        
TLR4
     
CU-CPT-9a  
TLR8, IC50: 0.5 nM
            99.36%
CpG ODN 10101    
TLR9
         
CU-CPT-8m  
TLR8, IC50: 67 nM
            99.98%
CL264          
TLR7
    98.63%
Monophosphoryl lipid A        
TLR4
      ≥99.0%
CAY10614        
TLR4, IC50: 1.675 μM (in HEK293 cells)
      98.04%
TLR7/8 agonist 3  
TLR8
     
TLR7
    99.96%
CU-CPT17e
TLR3
TLR8
TLR9
          99.00%
DSR-6434          
TLR7, EC50: 7.2 nM (Human)
TLR7, EC50: 4.6 nM (Mice)
    99.55%
Procyanidin B3        
TLR4
      99.63%
TLR7 agonist 3          
TLR7
    99.90%
Kaempferol 3-O-sophoroside      
TLR2
TLR4
      99.84%
GSK2245035          
TLR7
    99.85%
L6H21        
TLR4
      99.46%
ODN 20844    
TLR9
   
TLR7
   
ODN M362    
TLR9
         
CU-115  
TLR8, IC50: 1.04 μM
     
TLR7, IC50: 50 μM
    99.55%
AN-3485
TLR3
   
TLR2
TLR4
     
Imiquimod maleate          
TLR7
    99.25%
LHC-165          
TLR7
    ≥98.0%
Fosfenopril        
TLR4
      99.89%
E6446    
TLR9
   
TLR7
    ≥98.0%
TLR7/8 agonist 4  
TLR8
     
TLR7
    99.04%
CU-CPT9b  
TLR8, IC50: 0.7 nM
TLR8, Kd: 21 nM
            99.03%
Polygalasaponin F        
TLR4
      99.85%
ssRNA40 sodium  
TLR8
     
TLR7
   
1V209          
TLR7
    99.67%
Toll-like receptor modulator  
TLR8
     
TLR7
    99.36%
RKH acetate        
TLR4
      99.45%
Resiquimod (GMP)  
TLR8
     
TLR7
   
PF-4878691          
TLR7
    99.89%
AZD8848          
TLR7
    99.14%
Chloranil        
TLR4
      98%
MAPK-IN-1        
TLR4
     
TLR7 agonist 6          
TLR7, EC50: ~4 nM
    98.08%
Resiquimod-d5  
TLR8
     
TLR7
    99.84%
TLR7 agonist 1          
TLR7, IC50: 90 nM
    98.95%
MMG-11 quarterhydrate      
TLR2
        99.09%
ODN 24987    
TLR9
         
SMU-L11          
TLR7, EC50: 0.024 μM
    99.64%
SM-324405          
human TLR7, pEC50: 7.3
Rat TLR7, pEC50: 6.6
TLR7, EC50: 50 nM
    98.52%
FAM-labeled ODN 1826 sodium    
TLR9
          98.03%
CL097 hydrochloride  
TLR8
     
TLR7
    99.51%
Diprovocim-X      
TLR2
   
TLR1
  98.64%
E104          
TLR7
   
TLR4-IN-C34-C2-amide-C6-OH        
TLR4
      99.62%
TMX-201          
TLR7
   
Kdo2-Lipid A ammonium        
TLR4
      99.00%
BBIQ          
TLR7, EC50: 59.1 nM (Human TLR7)
    99.85%
ODN M326 sodium    
TLR9
         
ORN 06 sodium          
TLR7
   
MC-Val-Cit-PAB-Amide-TLR7 agonist 4  
TLR8
     
TLR7
    99.39%
TLR7 agonist 4          
TLR7, EC50: 4.3 nM
    98.87%
TLR7/8 agonist 8  
TLR8, EC50: 12 nM
     
TLR7, EC50: 27 nM
   
FSL-1      
TLR2
     
TLR6
Pam3CSK4      
TLR2
   
TLR1
 
TLR7 agonist 20 hydrochloride  
TLR8, EC50: 17.21 μM
     
TLR7, EC50: 0.23 μM
    99.86%
AXC-715 hydrochloride  
TLR8
     
TLR7
    99.46%
PVP-037.2  
TLR8
     
TLR7
   
Hydroxychloroquine sulfate (Standard)    
TLR9
   
TLR7
    99.28%
ODN 24888    
TLR9
   
TLR7
   
(S)-Hydroxychloroquine    
TLR9
   
TLR7
   
(R)-Hydroxychloroquine    
TLR9
   
TLR7
   
Guretolimod          
TLR7
   
TLR7/8 agonist 4 TFA  
TLR8
     
TLR7
   
TLR8 agonist 2 hydrochloride  
TLR8, EC50: 3 nM
     
TLR7, EC50: 33.33 μM
   
TLR8 agonist 2  
TLR8, EC50: 3 nM
     
TLR7, EC50: 33.33 μM
   
UC-1V150          
TLR7
   
TLR7-IN-1          
TLR7, IC50: 0.001 μM
   
WYJ-2      
TLR2
       
TLR7 agonist 27          
TLR7, EC50: 238.1 nM
   
TLR2 agonist 1      
hTLR2, EC50: 116 pM
       
Tri(TLR4-IN-C34-C2-amide-C3-amide-PEG1)-amide-C3-COOH        
TLR4
     
TLR7 agonist 24          
TLR7, EC50: 3.72 μM
   
TLR7 agonist 14          
TLR7, IC50: 18 nM
   
Cholesterol oxidase, rhodococcus sp      
TLR2
       
TLR7 agonist 21  
TLR8, EC50: 5932 nM
     
human TLR7, EC50: 17.53 nM
mTLR7, EC50: 41.7 nM
   
TLR7 agonist 7          
TLR7, EC50: ~4 nM
   
3M-011  
TLR8
     
TLR7
   
TLR8 agonist 8  
TLR8
           
TLR7 agonist 20  
TLR8, EC50: 17.21 μM
     
TLR7, EC50: 0.23 μM
   
ODN M326    
TLR9
         
TLR7 agonist 26          
TLR7, EC50: 225.5 nM
   
TLR7 agonist 8          
TLR7, EC50: ~4 nM
   
ORN 06          
TLR7
   
TLR8 agonist 7  
TLR8
           
NF-κB-IN-14        
TLR4
     
Rabeximod      
TLR2
TLR4
     
TLR7 agonist 9          
TLR7
   
TLR8 agonist 9  
TLR8
           
Xanthine oxidase-IN-6        
TLR4
     
Vidutolimod    
TLR9
         
BI1543673  
TLR8
   
TLR4
TLR7
   
Mumefural        
TLR4
     
RC529-MDP        
TLR4
     
Tri(TLR4-IN-C34-C2-amide-PEG1)-amide-C3-COOH        
TLR4
     
TLR7 agonist 17          
human TLR7, EC50: 12 nM
mTLR7, EC50: 17 nM
   
Polyinosinic-polycytidylic acid potassium
TLR3
             
Eritoran        
TLR4
     
TLR7/8 agonist 11  
TLR8, EC50: 13.1 nM
     
human TLR7, EC50: 31.1 nM
   
Pam3CSK4-Biotin      
TLR2
   
TLR1
 
M199
TLR3
 
TLR9
         
MTT5          
TLR7
   
ORN 02 sodium  
TLR8
           
ORN 02  
TLR8
           
Macrophage-activating lipopeptide 2      
TLR2
     
TLR6
TLR7 agonist 5          
TLR7, EC50: ~4 nM
   
AYK004  
TLR8
     
TLR7
   
AYK004-B1          
TLR7, EC50: 0.2265 nM
   
Isatoribine          
TLR7
   
UM-3006  
TLR8
     
TLR7
   
BBIQ (GMP)          
human TLR7, EC50: 59.1 nM